IGF-1 DES vs Somatropin

Head-to-head comparison of IGF-1 DES (Des(1-3) Insulin-like Growth Factor 1) and Somatropin (Recombinant human growth hormone (rhGH)) — benefits, dosing, side effects, research data, and where to buy.

Research Score

PropertyIGF-1 DESSomatropin
CategoryGrowth HormoneGrowth Hormone
Full NameDes(1-3) Insulin-like Growth Factor 1Recombinant human growth hormone (rhGH)
Molecular Weight7365 Da22125 Da
Half-Life~20-30 minutes2-4 hours
Amino Acids67191
Typical Dose0.004-0.03 mg/kg/day
RouteSubcutaneous
Purity>98%≥98%
Studies Count652000
Research StatusActive ResearchClinical/Approved

IGF-1 DES Benefits

  • Highly potent localized muscle growth, enhanced protein synthesis, satellite cell proliferation, does not bind to IGFBPs, rapid onset

Somatropin Benefits

  • linear growth support
  • lean mass preservation
  • bone mineral accrual
  • IGF-1 elevation

IGF-1 DES Dosing

50-150 mcg per injection site bilaterally post-workout. 4-6 week cycles due to potency. Multiple daily injections in research.

Somatropin Dosing

daily subcutaneous dosing|titrate to IGF-1 and response|weight-based replacement protocols

IGF-1 DES Side Effects

  • Hypoglycemia (dose-dependent), localized swelling, shorter duration limits systemic exposure compared to IGF-1 LR3.

Somatropin Side Effects

  • edema
  • arthralgia
  • insulin resistance

Research Overview

IGF-1 DES

Missing first three amino acids (Gly-Pro-Glu) eliminates IGFBP binding, resulting in 100% bioavailable IGF-1R stimulation. Activates PI3K/Akt/mTOR for protein synthesis and satellite cell proliferation.

Somatropin

Somatropin is the best-studied growth hormone peptide, with decades of clinical use in pediatric and adult GH deficiency. Trials consistently show increases in IGF-1 and growth velocity, with adverse effects mainly reflecting excessive GH exposure.

Ready to buy?

Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.

Common Stacking Partners

IGF-1 DES stacks with:

PEG-MGFIGF-1 LR3CJC-1295
growth-factorIGF-1-analogmuscle-growthanaboliclocalized-growthgh-axisigf-1clinical